Eli Lilly Buys AtaiBeckley to Expand Depression Pipeline
Eli Lilly’s $2.8B cash deal plus up to $1B in CVRs to buy AtaiBeckley adds FDA Breakthrough BPL‑003 for TRD, with closing eyed Q3 2026.
- Read at CryptoDaily
- Fri, 17 Jul 2026 15:01:50 +0100
Eli Lilly’s $2.8B cash deal plus up to $1B in CVRs to buy AtaiBeckley adds FDA Breakthrough BPL‑003 for TRD, with closing eyed Q3 2026.